And you thought Mastadons were extinct …
by KIM BELLARD
Until last week, for me, “mastodon” only meant the giant animal that went extinct several thousand years ago (I was, it appears, unaware of the heavy metal band Mastodon). Now, as the result of Elon Musk’s purchase of Twitter, many Twitter users are being forced to take a look at alternatives, such as the social networking site Mastodon.
It’s possible that we are about the witness the Myspace-ization of Twitter, brought down by competition, bad management, and bad product decisions. In my usual “there must be a pony in here somewhere” fashion, there may be some lessons in the Twitter saga ...
Source: The Health Care Blog - November 8, 2022 Category: Consumer Health News Authors: matthew holt Tags: Health Tech Elon Musk Kim Bellard Mastadon Twitter Source Type: blogs
Precision psychiatry pioneer Alto Neuroscience raises $35M to advance digital biomarker-to-treatment platform
Alto Neuroscience Raises $35M Series B Financing (FinsMes):
Alto Neuroscience, a Los Altos, CA-based neuro-tech company which specializes in precision psychiatry, raises $35M Series B Financing … The company intends to use the funds to advance lead candidates into Phase 2b studies in major depressive disorder … Proceeds from the financing will also be used to progress the company’s artificial intelligence-enabled brain biomarker platform and launch new clinical trials in areas of high unmet medical need. Alto will report Phase 2a data in early 2023 and further anticipates Phase 2b data readouts by early 2024.
Led by ...
Source: SharpBrains - November 7, 2022 Category: Neuroscience Authors: SharpBrains Tags: Brain/ Mental Health Technology & Innovation Alto Neuroscience Amit Etkin artificial intelligence brain biomarker EEG activity Major Depressive Disorder neuro-tech precision psychiatry Source Type: blogs
A View Into the World of LTPAC at the PointClickCare Summit
As we continue our ongoing coverage of Fall Health IT conferences, I’m happy this week to finally being able to attend the PointClickCare Summit. I’ve been invited for a long time, but the timing never worked out. If you’re not familiar with PointClickCare, then you probably don’t work in the LTPAC space. They’re kind of like the Epic of LTPAC. I’m excited to be educated on the unique realities that LTPAC faces. Although, after hearing today’s opening keynote, many of the issues in LTPAC are very similar to acute care with slight twists.
Here’s a look at some of the...
Source: EMR and HIPAA - November 2, 2022 Category: Information Technology Authors: John Lynn Tags: C-Suite Leadership Communication and Patient Experience EMR-EHR Health IT Company Healthcare IT Interoperability LTPAC Audacious Inquiry Collective Medical COVID-19 Dave Wessinger LTPAC Referrals Mike Wessinger PointClickCare S Source Type: blogs
Rethinking Newer Events
BY KIM BELLARD
It’s a lot more fun to write about exciting new technologies, or companies in other industries that healthcare could learn from, than to pick on healthcare for its many, well-known shortcomings, but there was an article in JAMA Forum last week that I had to note and perhaps expand on: A New Category of “Never Events” – Ending Harmful Hospital Policies, by Dave A. Chokshi, MD, MSc and Adam L. Beckman, BS (he is also an MD/MBA student).
The concept of a “Never Event” is well known by this point. Coined some twenty years ago by Ken Kizer, MD of the National Quality Form (NQF) and soon w...
Source: The Health Care Blog - November 1, 2022 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Health Policy Public Health Kim Bellard medical debt Never Event sustainable development Source Type: blogs
COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation
Financing will be used to accelerate and further diversify COTA’s oncology real-world data products and services
COTA, Inc., an oncology real-world data and analytics company, announced its latest financing by an investment fund managed by Deerfield Management, a healthcare investment firm. Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. In conjunction, COTA announced it has raised additional capital from existing investors. The company will use this new funding to further expand its real-world data platform and services...
Source: EMR and HIPAA - November 1, 2022 Category: Information Technology Authors: Healthcare IT News Tags: Genomics-Precision Medicine Health IT Company Healthcare IT Baptist Health South Florida Bristol-Myers Squibb Clinicogenomics COTA COTA Inc. data analytics Deerfield Deerfield Management EMA European Medicines Agency FDA Food a Source Type: blogs
Bonus Features – October 30, 2022 – 46% of Americans have gone into debt paying medical bills, 41% say retail and virtual care experiences are disjointed, and more
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
News and Studies
A survey from digital health platform Babylon found that 46% of Americans have gone into debt from their medical bills, while 34% are currently struggling to pay their medical and insurance bills. In addition, ...
Source: EMR and HIPAA - October 30, 2022 Category: Information Technology Authors: Brian Eastwood Tags: Ambulatory C-Suite Leadership Communication and Patient Experience Health IT Company Healthcare IT Hospital - Health System LTPAC Revenue Cycle Management Altus Amazon Amazon Healthcare Aspen RxHealth athenahealth AtlantiCare B Source Type: blogs
Pfizer ’s Biotech Strategy: When a “Market Force” Partners with a “Market Mover”
by JESSICA DAMASSA, WTF HEALTH
The synergistic relationship between biotech’s and biopharma’s can dramatically change the way new drugs and vaccines are bought to market – helping advance innovation on BOTH sides in a very mutually beneficial way. I’ve got an inside look at how Pfizer is working with emerging biotech start-ups, thanks to this in-depth chat with Pfizer’s Senior Vice President of Business Innovation, Kathy Fernando.
Kathy is not only responsible for developing relationships with biotech’s on behalf of Pfizer, BUT during the pandemic she led Pfizer’s mRNA scientific strategy, ...
Source: The Health Care Blog - October 27, 2022 Category: Consumer Health News Authors: matthew holt Tags: Pharmaceuticals biopharma Innovation Jessica DaMassa Pfizer Source Type: blogs
The Macro View – Health, Economics, and Politics and the Big Picture. What I Am Watching Here And Abroad.
October 27, 2022 Edition-----In the UK we have a political farce running with only a day or so to run when you read this, with a new PM (Rishi Sunak) in place..In the US the mid-term elections are coming in a week or so, thus some concern as to where the US is going!In China Xi has his third 5 year term so we all wonder how that will turn out!In OZ we have has a Budget with floods, inflation, data leaks, the threat of recession, Medicare concerns and other issues just rolling on! At least the Budget does not seem to have broken anything!Overall an ‘omnishambles’ as they say!-----Major Issues.-----https://www.afr.com/wo...
Source: Australian Health Information Technology - October 27, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Future of Big Data in Health? LexisNexis ® Risk Solutions Says Next-Gen Tokenization & Health Equity
BY JESSICA DaMASSA, WTF HEALTH
Data-juggernaut LexisNexis® Risk Solutions is making a big data play in healthcare, launching a new capability that allows for unprecedented accuracy in the kind of de-identified data that payers, providers, and pharma are clamoring to use for everything from cutting admin expenses to improving patient outcomes and health equity.
Jeff Diamond, President & General Manager of The Health Care Business of LexisNexis® Risk Solutions and Andrea Green, Director of Healthcare Strategy, SDoH, drop in for a chat about all things VERY big data, including this concept of “next-gen tokeniza...
Source: The Health Care Blog - October 25, 2022 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Health Tech WTF Health health equity LexisNexis Next-Gen Tokenization Source Type: blogs
Art Is in the Eye of the Computer
BY KIM BELLARD
It turns out that I’ve been writing about Generative AI without even realizing there was something called Generative AI, such as articles about the robot artist Ai-Da, the AI image creator DALL-E, or patent protection for AI inventors. Generative AI refers to AI that strives not just to process and synthesize data but to actually be creative. It’s starting to both become more widespread and to attract serious attention from investors.
James Currier of investment firm NFX sees “Generative Tech” as the next big thing: “If crypto hadn’t happened, we’d probably be calling THIS Web3.”...
Source: The Health Care Blog - October 25, 2022 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Health Policy Health Tech Public Health Ai-Da DALL-E Kim Bellard Source Type: blogs
Mark Cuban CostPlus Drug Company Is Distributing Roche Accu-Chek Testing Supplies
Taking a bit of a break from my recent podcast recommendations, but kind of an extension of the previous one about theMark Cuban CostPlus Drug Company, on October 11, 2022, Mark Cuban ' s startup known as the Mark Cuban CostPlus Drug Company ( " MCCPDC " , in different notices shared on Twitter, LinkedIn, Facebook, etc.) announced a partnership with Roche Diabetes Care to bring CostPlus Drugs patients to buy Accu-Chek testing supplies through them at a lower price. Thecost of buying Accu-Chek test strips from CostPlus is $16.79 for a quantity of 50 test strips. That works out to a cost of $0.34 per strip. Price-...
Source: Scott's Web Log - October 23, 2022 Category: Endocrinology Tags: 2022 Accu-Chek cash price costplus drug company mark cuban Roche Source Type: blogs
Fight Aging! Newsletter, October 24th 2022
This study shows the uncoupling of lifespan and healthspan parameters (aerobic fitness and spontaneous activity) and provides new insights into SIRT3 function in CR adaptation, fuel utilization, and aging.
HDL Level, Age, and Smoking are the Largest Determinants of Mortality Risk in Old People
https://www.fightaging.org/archives/2022/10/hdl-level-age-and-smoking-are-the-largest-determinants-of-mortality-risk-in-old-people/
An interesting epidemiological study here stratifies the contributions of various metrics to mortality in later life, age 70 and older. The authors find that the largest effects arise...
Source: Fight Aging! - October 23, 2022 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Podcast Recommendation: Global Healthy Living Foundation " How I Built This Lab With Guy Raz "
So, next up on my podcast recommendation (and incidentally, I should note that my recommendations are for specific podcast episodes, not necessarily all episodes within a given podcast, although you may also like subscribing to certain podcasts as the content tends to e similar to an episode I ' m recommending) is one I only occasionally listen to if the topic sounds interesting. The podcast episode I am recommending today is one created by NPR called the " How I Built This Lab With Guy Raz " podcast (Guy Raz is the name of the host) in which he interviewed billionaire Mark Cuban. Mr. Cuban was on this particular podc...
Source: Scott's Web Log - October 22, 2022 Category: Endocrinology Tags: costplus drug company how i built this lab mark cuban NPR podcast Source Type: blogs
Podcast Recommendation: " How I Built This Lab With Guy Raz "
So, next up on my podcast recommendation (and incidentally, I should note that my recommendations are for specific podcast episodes, not necessarily all episodes within a given podcast, although you may also like subscribing to certain podcasts as the content tends to be similar to an episode I ' m recommending) is one I only occasionally listen to if the topic sounds interesting. The podcast episode I am recommending today is one created by NPR called the " How I Built This Lab With Guy Raz " podcast (Guy Raz is the name of the host) in which he interviewed billionaire Mark Cuban. Mr. Cuban was on this particular pod...
Source: Scott's Web Log - October 22, 2022 Category: Endocrinology Tags: costplus drug company how i built this lab mark cuban NPR podcast Source Type: blogs
Podcast Recommendation: " How I Built This Lab With Guy Raz " Episode With Mark Cuban on His CostPlus Drug Co.
So, next up on my podcast recommendation (and incidentally, I should note that my recommendations are for specific podcast episodes, not necessarily all episodes within a given podcast, although you may also like subscribing to certain podcasts as the content tends to be similar to an episode I ' m recommending) is one I only occasionally listen to if the topic sounds interesting. The podcast episode I am recommending today is one created by NPR called the " How I Built This Lab With Guy Raz " podcast (Guy Raz is the name of the host) in which he interviewed billionaire Mark Cuban. Mr. Cuban was on this particular pod...
Source: Scott's Web Log - October 22, 2022 Category: Endocrinology Tags: costplus drug company how i built this lab mark cuban NPR podcast Source Type: blogs
